- Training
- 90 Minutes
Europe
- Report
- September 2022
- 70 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- September 2022
- 89 Pages
Global
From €3153EUR$3,500USD£2,782GBP
- Report
- September 2022
- 54 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- September 2022
- 65 Pages
Global
From €3153EUR$3,500USD£2,782GBP
- Report
- August 2022
- 104 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- June 2022
- 78 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- December 2022
- 94 Pages
Global
From €1802EUR$2,000USD£1,590GBP
- Report
- October 2022
- 308 Pages
Global
From €2252EUR$2,500USD£1,987GBP
- Report
- May 2022
- 68 Pages
Global
From €1802EUR$2,000USD£1,590GBP
-
Journal - November 2025
- 60 Pages
Global
From €383EUR$425USD£338GBP
- Book
- June 2002
- 356 Pages
Europe
- Training
- 3 Hours
Brazil

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards.
Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more